2,3,4,5-Tetrahydro-1H-benzo[b]azepin-8-ol, 98%, 250mg

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile, 95+%, 1g

4-CYANO-3-METHYLBENZALDEHYDE, 95.0%, 1g

4-(5-Methyl-3-phenylisoxazol-4-yl)benzene-1-sulfonyl chloride, 95.0%, 10g

2-Methyl-4-(methylsulfonyl)benzoic acid, 95.0%, 5g

6-Bromoimidazo[1,2-a]pyrimidine-2-carboxylic acid, 97%, 250mg

cis-5-Benzyl-2-Boc-hexahydropyrrolo[3,4-c]pyrrole, 95.0%, 1g

3-methyl-4-(pyridin-3-yloxy)aniline, 95.0%, 1g

3-ETHYNYL-PYRIDAZINE, 95.0%, 500mg

1,2-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyne, 98+%, 1g

5-Chloro-2-(methylthio)-4-(trifluoromethyl)pyrimidine, 98%, 250mg

Recipiente de transporte Dewar Tipo B (funda metálica, azul), 28 B, 3 l, 138 mm, 1 Pieza

Methyl 2,3,6-Tri-O-benzoyl-alpha-D-galactopyranoside>98.0%(HPLC)5g